GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

The Bank of England risks inflicting unnecessary damage to the economy by keeping interest rates too high for too long, a ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...

ShareUK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

0544 ET – GSK’s $2.2 billion settlement to resolve the majority of Zantac litigation cases was welcomed by the market, with ...

Lawyers representing 10 groups of plaintiffs, or 80,000 liability cases across the US, have backed the payout. There remain another few thousand cases not covered by the payout. GSK will also pay a ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

The FTSE 100 index closed down 6.01 points, 0.1%, at 8,237.73. The FTSE 250 ended 114.01 points lower, 0.6%, at 20,708.37, and the AIM All-Share fell 2.13 points, 0.3%, to 734.53.

The UK's main stock indexes slipped on Thursday as some of the companies traded without the entitlement of their dividend pay ...

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

The superstorm is expected to inflict costly and lasting damage in Florida, as the Federal Reserve is already keeping an eye ...